Drug Side Effects

Tag Archive

Warned: Non-Medical COVID-19 Treatment Producers

Warned: Non-Medical COVID-19 Treatment Producers

| Pharmaceutical Litigation
The Federal Trade Commission and Food and Drug Administration recently told seven companies to either stop selling certain products or revise their claims. In a mass letter to Vital Silver, GuruNanda, LLC, Vivify Holistic Clinic, Herbal Amy LLC, Quinessence Aromatherapy Ltd., Xephyr, LLC doing business as N-Ergetics, and The Jim Baker Show, regulators said these…Read the article
Medtronic Recalls Faulty Insulin Pumps

Medtronic Recalls Faulty Insulin Pumps

| Pharmaceutical Litigation
After evidence of a possible life-threatening defect came to light, Medtronic, the medical device giant issued an immediate recall for its MiniMed Insulin Pumps. The recall covers over 300,000 devices which were sold in the United States beginning in June 2017. Medtronic touted these pumps as safe to use for people as young as seven…Read the article
Bladder Medication Can Cause Blindness

Bladder Medication Can Cause Blindness

| Pharmaceutical Litigation
Orphan drug affects eyesight Having been widely prescribed for decades, the Elmiron bladder medication has recently been found to be toxic to the retina (damage). An article published by the American Academy of Ophthalmology in 2018 described six patients experiencing pigmentary maculopathy after chronic exposure to Elmiron (pentosan polysulfate sodium) for interstitial cystitis. The following…Read the article
Prescription Weight Loss Drug Pulled Off The Market

Prescription Weight Loss Drug Pulled Off The Market

| Pharmaceutical Litigation
In 2012, the FDA approved the first new prescription weight loss drug in thirteen years: lorcaserin, marketed as Belviq. Available to patients in the US since June 2013 in a twice-daily dose, it was soon (2016) followed by once-a-day Belviq XR. Expectations crushed Nevertheless, this herald of hope for almost one third of Americans rated…Read the article
Headaches Ahead for Zantac Labs

Headaches Ahead for Zantac Labs

| Pharmaceutical Litigation
Heartburn Heaven As recently as August 2019, the ranitidine market was tipped to top a gut-gripping US$ 485.4 million by 2026. Introduced in 1981, this popular antacid – better known as Zantac – was the world’s top-selling prescription drug just six years later. In fact, sweetening the world’s sour stomachs proved a bottomless well of…Read the article
Prescription Drug Elmiron May Cause Vision Loss

Prescription Drug Elmiron May Cause Vision Loss

| Pharmaceutical Litigation
A medication that is prescribed to treat various bladder issues has been linked to a rare vision problem known as pigmentary maculopathy, and other conditions which can cause the victim to lose his or her sight. Recent research reports show that condition occurs in patients who have been using Elmiron long-term and is causing vision…Read the article
FDA Demands Zantac Recall

FDA Demands Zantac Recall

| Pharmaceutical Litigation
Recent evidence links the popular heartburn medication to an increased cancer risk, thus FDA demands Zantac recall. The agency wants all ranitidine off store shelves effective immediately. Currently, the Food and Drug Administration is sending letters to Sanofi and other ranitidine manufactures asking them to stop making and shipping product. Additionally, the FDA advises consumers…Read the article
Disturbing Link: Cosmetic Products and Serious Injuries

Disturbing Link: Cosmetic Products and Serious Injuries

| Personal Injury
Every year, thousands of young children are too near toxic household products. Every year, these close encounters send thousands of victims to the emergency room. According to the U.S. Consumer Product Safety Commission, the vast majority of these victims are children under 5. Many of these injuries happen after children were exposed to products that…Read the article
Uloric Lawsuit Claims and Process

Uloric Lawsuit Claims and Process

| Pharmaceutical Litigation
We trust our doctors and trained medical professionals to take care of us and recommended medications that will keep us safe and healthy and that won’t end up causing more harm than good. Unfortunately, more and more often these days, medications are being shown to have known risks and dangers associated with them. Many of…Read the article
Lemtrada Stroke and Arterial Tears Risk

Lemtrada Stroke and Arterial Tears Risk

| Pharmaceutical Litigation
The U.S. Food and Drug Administration (FDA) has put forth an urgent safety alert, in regards to some rare but very life-threatening risks including stroke and artery rupture. The patients at risk are those who have relapsing forms of multiple sclerosis (MS) and are currently being treated with Lemtrada (alemtuzumab). Since Lemtrada’s approval in 2014 to treat relapsing MS, 13 cases worldwide have been…Read the article